Disease | metabolic syndrome x |
Symptom | |hypertension |
Sentences | 113 |
PubMedID- 26504474 | Increased fructose ingestion has been linked to obesity, hyperglycemia, dyslipidemia, and hypertension associated with metabolic syndrome. |
PubMedID- 24507240 | Did not distinguish subgroups for those with or without hypertension in the population of patients with metabolic syndrome . |
PubMedID- 25758604 | Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome. |
PubMedID- 22534714 | Obesity and arterial hypertension are both components of metabolic syndrome; moreover, adipose tissue is considered to be a potent hypertensive agent. |
PubMedID- 22940679 | Objective: nonalcoholic fatty liver and hypertension are associated with metabolic syndrome. |
PubMedID- 20556204 | Ldl-c, triglycerides, uric acid, bmi, serum glucose, metabolic syndrome, smoking, hypertension and prehypertension), some of which are commonly found in patients with pbc. |
PubMedID- 25993638 | Increased cardiovascular mortality in subjects with metabolic syndrome is largely attributable to diabetes and hypertension in 159,971 korean adults. |
PubMedID- 24441717 | Although a wide range of potentially therapeutic effect of asiatic acid have been reported, little is known about the effect of asiatic acid on metabolic syndrome associated with hypertension in diet-induced ms. the aim of the present study was to investigate whether asiatic acid can improve metabolic and cardiovascular complications in an animal model of hchf diet-induced metabolic syndrome. |
PubMedID- 21516767 | Pathogenetic aspects of arterial hypertension in metabolic syndrome. |
PubMedID- 20972515 | Urbanisation is associated with obesity, hypertension and development of the metabolic syndrome (ms). |
PubMedID- 23876229 | Obesity and associated diseases such as type 2 diabetes dyslipidemia, and hypertension, i.e., components of the metabolic syndrome 1, are a major public health problem. |
PubMedID- 23849214 | Abpm should be a priority for persons likely to have a blunted nighttime bp decline and elevated cvd risk, i.e., those who are elderly and obese, those with secondary or resistant hypertension, and those diagnosed with diabetes, ckd, metabolic syndrome, and sleep disorders. |
PubMedID- 21390196 | Fifty nine had isolated metabolic syndrome (group a) and 97 had metabolic syndrome with hypertension and/or diabetes (group b). |